Xevudy, Konzentrat zur Herstellung einer Infusionslösung

7680684710018 CH-68471 Konzentrat
Xevudy, Konzentrat zur Herstellung einer Infusionslösung
Xevudy, Konzentrat zur Herstellung einer Infusionslösung
Xevudy, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/06/2025
Summary of Product Characteristics
Français
26/06/2025
Summary of Product Characteristics
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
68471
Drug name
Xevudy, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
J06BD05
Authorization status
Z
Dispensing category
A
First authorization
14/01/2022
Authorization expiration date
18/03/2029
IT Number
08.03.0.
Domain
Human medicine
Field of application
Behandlung von COVID-19

Package details

Description (FR)
XEVUDY conc perf 500 mg/8ml flac 8 ml
Description (DE)
XEVUDY Inf Konz 500 mg/8ml Durchstf 8 ml
Market launch
14/01/2022
Narcotic (BTM)
No